Pervan, M.; Marijan, S.; Markotić, A.; Pilkington, L.I.; Haverkate, N.A.; Barker, D.; Reynisson, J.; Meić, L.; Radan, M.; Čikeš Čulić, V.
Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism. Int. J. Mol. Sci. 2022, 23, 11457.
https://doi.org/10.3390/ijms231911457
AMA Style
Pervan M, Marijan S, Markotić A, Pilkington LI, Haverkate NA, Barker D, Reynisson J, Meić L, Radan M, Čikeš Čulić V.
Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism. International Journal of Molecular Sciences. 2022; 23(19):11457.
https://doi.org/10.3390/ijms231911457
Chicago/Turabian Style
Pervan, Matij, Sandra Marijan, Anita Markotić, Lisa I. Pilkington, Natalie A. Haverkate, David Barker, Jóhannes Reynisson, Luka Meić, Mila Radan, and Vedrana Čikeš Čulić.
2022. "Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism" International Journal of Molecular Sciences 23, no. 19: 11457.
https://doi.org/10.3390/ijms231911457
APA Style
Pervan, M., Marijan, S., Markotić, A., Pilkington, L. I., Haverkate, N. A., Barker, D., Reynisson, J., Meić, L., Radan, M., & Čikeš Čulić, V.
(2022). Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism. International Journal of Molecular Sciences, 23(19), 11457.
https://doi.org/10.3390/ijms231911457
